Casdin Capital
$1.3B Assets Reported
47 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,577,333 | $251M | 19.0% |
| WGS | GENEDX HOLDINGS CORP | 3,007,164 | $193M | 14.6% |
| RLAY | RELAY THERAPEUTICS INC | 14,418,574 | $143M | 10.9% |
| BLFS | BIOLIFE SOLUTIONS INC | 5,957,165 | $114M | 8.6% |
| LAB | STANDARD BIOTOOLS INC | 88,783,856 | $82M | 6.2% |
| ILMN | ILLUMINA INC | 530,000 | $65M | 4.9% |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,175,000 | $57M | 4.3% |
| TXG | 10X GENOMICS INC | 2,275,000 | $48M | 3.7% |
| DNLI | DENALI THERAPEUTICS INC | 1,840,000 | $35M | 2.7% |
| BEAM | BEAM THERAPEUTICS INC | 1,350,000 | $32M | 2.4% |
Track Casdin Capital's 13F portfolio: $1.3B in reported holdings, 47 positions. Top holdings, AUM, and quarterly changes on SentiSense.